Business Description
ODI Pharma AB
ISIN : SE0013409760
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -7.4 | |||||
3-Year EPS without NRI Growth Rate | -7.7 | |||||
3-Year FCF Growth Rate | 1.3 | |||||
3-Year Book Growth Rate | -49.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.49 | |||||
9-Day RSI | 37.16 | |||||
14-Day RSI | 37.44 | |||||
6-1 Month Momentum % | 5.26 | |||||
12-1 Month Momentum % | 19.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.29 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.5 | |||||
Days Inventory | 22.53 | |||||
Days Sales Outstanding | 42.83 | |||||
Days Payable | 56.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.09 | |||||
Operating Margin % | -8.09 | |||||
Net Margin % | -12.01 | |||||
FCF Margin % | -12.75 | |||||
ROE % | -61.13 | |||||
ROA % | -19.65 | |||||
ROIC % | -28.74 | |||||
3-Year ROIIC % | -39.64 | |||||
ROC (Joel Greenblatt) % | -819.2 | |||||
ROCE % | -38.88 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.86 | |||||
PB Ratio | 20.09 | |||||
Price-to-Tangible-Book | 16.2 | |||||
EV-to-EBIT | -48.26 | |||||
EV-to-EBITDA | -48.48 | |||||
EV-to-Revenue | 3.69 | |||||
EV-to-FCF | -32.93 | |||||
Price-to-Net-Current-Asset-Value | 16.2 | |||||
Earnings Yield (Greenblatt) % | -2.07 | |||||
FCF Yield % | -3.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ODI Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.271 | ||
EPS (TTM) (€) | -0.009 | ||
Beta | 0.79 | ||
Volatility % | 54.26 | ||
14-Day RSI | 37.44 | ||
14-Day ATR (€) | 0.017716 | ||
20-Day SMA (€) | 0.3698 | ||
12-1 Month Momentum % | 19.57 | ||
52-Week Range (€) | 0.218 - 0.65 | ||
Shares Outstanding (Mil) | 15.22 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ODI Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ODI Pharma AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
ODI Pharma AB Frequently Asked Questions
What is ODI Pharma AB(FRA:6OD)'s stock price today?
When is next earnings date of ODI Pharma AB(FRA:6OD)?
Does ODI Pharma AB(FRA:6OD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |